Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             35 results found
no title author magazine year volume issue page(s) type
1 Abnormal glucose tolerance and the 50-gram glucose challenge test in Cystic fibrosis Sheikh, Saba

19 5 p. 696-699
article
2 Accumulation and persistence of ivacaftor in airway epithelia with prolonged treatment Guhr Lee, Tara N.

19 5 p. 746-751
article
3 Amplifiers co-translationally enhance CFTR biosynthesis via PCBP1-mediated regulation of CFTR mRNA Dukovski, Danijela

19 5 p. 733-741
article
4 Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy Gifford, Alex H.

19 5 p. 762-767
article
5 Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis Tarique, Abdullah A.

19 5 p. 823-829
article
6 Building global development strategies for cf therapeutics during a transitional cftr modulator era Mayer-Hamblett, N.

19 5 p. 677-687
article
7 Comment on "Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients" Ballmann, Manfred

19 5 p. 839
article
8 Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view De Boeck, K.

19 5 p. 688-695
article
9 Cystic fibrosis related diabetes: Revisiting the OGTT and alternate screening tests Chan, Christine L.

19 5 p. 671-672
article
10 Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis Colomba, Johann

19 5 p. 704-711
article
11 Editorial Board
19 5 p. ii
article
12 Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients Misgault, Bastien

19 5 p. 712-716
article
13 Eligibility of CFTR modulators for the adult-diagnosed cystic fibrosis population Desai, Sameer

19 5 p. 840-841
article
14 Endobronchial valve treatment of persistent alveolopleural fistulae in a patient with cystic fibrosis and empyema Bongers, Kale S.

19 5 p. e36-e38
article
15 Fibrocyte accumulation in the lungs of cystic fibrosis patients Kasam, Rajesh K.

19 5 p. 815-822
article
16 Formative evaluation of a dashboard to support coproduction of healthcare services in cystic fibrosis Van Citters, Aricca D.

19 5 p. 768-776
article
17 From disease mechanisms to novel therapies and back Farinha, Carlos M.

19 5 p. 673-674
article
18 Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action Laselva, Onofrio

19 5 p. 717-727
article
19 Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis Prentice, Bernadette J.

19 5 p. 700-703
article
20 Influenza B outbreak at an adult cystic fibrosis centre - Clinical impact and factors influencing spread Dennis, Jordan B

19 5 p. 808-814
article
21 In the south, if you give us lemons, we will make you lemonade Garcia, Bryan

19 5 p. 842-843
article
22 Intrinsic alterations in peripheral neutrophils from cystic fibrosis newborn piglets Bréa, Déborah

19 5 p. 830-836
article
23 In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells Rayner, Rachael E.

19 5 p. 752-761
article
24 Metabolomics profiling of tobacco exposure in children with cystic fibrosis Wisniewski, Benjamin L.

19 5 p. 791-800
article
25 News Article
19 5 p. 675-676
article
26 New therapies for people with CF in the CFTR modulator world Wainwright, Claire E

19 5 p. 669-670
article
27 No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy Scagnolari, Carolina

19 5 p. 837-838
article
28 Organizing pneumonia secondary to Exophiala dermatitidis in cystic fibrosis: A case report Radonjic, Aleksandar

19 5 p. e33-e35
article
29 R117H-CFTR function and response to VX-770 correlate with mRNA and protein expression in intestinal organoids Van Mourik, Peter

19 5 p. 728-732
article
30 Sleep disturbance and sleep insufficiency in primary caregivers and their children with cystic fibrosis Byars, Kelly C.

19 5 p. 777-782
article
31 Testicular pain following initiation of elexacaftor/tezacaftor/ivacaftor in males with cystic fibrosis Rotolo, Shannon M.

19 5 p. e39-e41
article
32 The specialist as primary care provider in CF Haywood, Kelsey B.

19 5 p. 844-845
article
33 Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis Oates, Gabriela R.

19 5 p. 783-790
article
34 Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway De, Prithwiraj

19 5 p. 801-807
article
35 Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy Guimbellot, Jennifer S.

19 5 p. 742-745
article
                             35 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands